Our lab works towards better therapies for rare immune diseases

Find out more about what we do, who we are, and how you can join us!
Learn about us


Our focus

Our group focuses on developing targeted therapies for rare immunological conditions, such as primary immunodeficiency diseases and immunological conditions of unknown origin.

Our aim

We aim to optimize the CRISPR-Cas gene editing technology as a gene therapy in these diseases, and stratify the existing therapies – such as biologic drugs and small molecule inhibitors – to better target the underlying molecular pathways that malfunction in individual patients.

Our methods

We utilize custom genomics methods and high-throughput screening to understand immune diseases and optimize CRISPR-Cas9 genome editing towards safe and efficient use in patients. We work with cell models and patient material, and strive to create teams with diverse expertise in molecular and computational biology and clinical medicine.

Who supports us?

Instrumentarium Science Foundation